Low-dose aspirin is being considered for primary prevention, with potential benefits and risks being weighed. The use of low-dose aspirin may be associated with an increased risk of peptic ulcers in new users, but it may also have benefits in treating or preventing cardiovascular disease and possibly blocking cancer metastasis. The effectiveness of low-dose aspirin for these purposes is being explored, although some outlets are also discussing other medications, such as rasburicase.